Kontraception til unge kvinder med fokus på langtidsvirkende reversible præventionsmidler

Pernille Ravn*, Kresten Rubeck Petersen

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

Long-acting, reversible contraceptives are about 20 times more effective in terms of contraceptive efficacy than oral hormonal contraceptives, patch or vaginal ring are. Long-acting, reversible contraceptives are not associated with serious adverse events but induce changes in menstrual bleeding pattern in about 75% of the users. The progestogen intrauterine device is effective in the treatment of menor­hagia and dysmenorrhoea. Increased use of long-acting reversible contraceptives is expected to reduce unplanned pregnancies and legal abortions in all ages. Concomitant use of barrier methods is important to prevent sexually transmitted diseases.
OriginalsprogDansk
ArtikelnummerV04170314
TidsskriftUgeskrift for Laeger
Vol/bind180
Udgave nummer4
Sider (fra-til)342-345
ISSN0041-5782
StatusUdgivet - 1. jan. 2018

Fingeraftryk

Contraceptive Agents
Contraceptives, Oral, Hormonal
Female Contraceptive Devices
Unplanned Pregnancy
Legal Abortion
Dysmenorrhea
Intrauterine Devices
Progestins

Citer dette

@article{3b15a7f1ae6f41d189445cb4bbfa0a39,
title = "Kontraception til unge kvinder med fokus p{\aa} langtidsvirkende reversible pr{\ae}ventionsmidler",
abstract = "Long-acting, reversible contraceptives are about 20 times more effective in terms of contraceptive efficacy than oral hormonal contraceptives, patch or vaginal ring are. Long-acting, reversible contraceptives are not associated with serious adverse events but induce changes in menstrual bleeding pattern in about 75{\%} of the users. The progestogen intrauterine device is effective in the treatment of menor­hagia and dysmenorrhoea. Increased use of long-acting reversible contraceptives is expected to reduce unplanned pregnancies and legal abortions in all ages. Concomitant use of barrier methods is important to prevent sexually transmitted diseases.",
author = "Pernille Ravn and Petersen, {Kresten Rubeck}",
year = "2018",
month = "1",
day = "1",
language = "Dansk",
volume = "180",
pages = "342--345",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "4",

}

Kontraception til unge kvinder med fokus på langtidsvirkende reversible præventionsmidler. / Ravn, Pernille; Petersen, Kresten Rubeck.

I: Ugeskrift for Laeger, Bind 180, Nr. 4, V04170314, 01.01.2018, s. 342-345.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Kontraception til unge kvinder med fokus på langtidsvirkende reversible præventionsmidler

AU - Ravn, Pernille

AU - Petersen, Kresten Rubeck

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Long-acting, reversible contraceptives are about 20 times more effective in terms of contraceptive efficacy than oral hormonal contraceptives, patch or vaginal ring are. Long-acting, reversible contraceptives are not associated with serious adverse events but induce changes in menstrual bleeding pattern in about 75% of the users. The progestogen intrauterine device is effective in the treatment of menor­hagia and dysmenorrhoea. Increased use of long-acting reversible contraceptives is expected to reduce unplanned pregnancies and legal abortions in all ages. Concomitant use of barrier methods is important to prevent sexually transmitted diseases.

AB - Long-acting, reversible contraceptives are about 20 times more effective in terms of contraceptive efficacy than oral hormonal contraceptives, patch or vaginal ring are. Long-acting, reversible contraceptives are not associated with serious adverse events but induce changes in menstrual bleeding pattern in about 75% of the users. The progestogen intrauterine device is effective in the treatment of menor­hagia and dysmenorrhoea. Increased use of long-acting reversible contraceptives is expected to reduce unplanned pregnancies and legal abortions in all ages. Concomitant use of barrier methods is important to prevent sexually transmitted diseases.

M3 - Tidsskriftartikel

AN - SCOPUS:85048983692

VL - 180

SP - 342

EP - 345

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 4

M1 - V04170314

ER -